CA2148112A1 - New pharmaeutical dosage form for transdermal administration - Google Patents

New pharmaeutical dosage form for transdermal administration

Info

Publication number
CA2148112A1
CA2148112A1 CA2148112A CA2148112A CA2148112A1 CA 2148112 A1 CA2148112 A1 CA 2148112A1 CA 2148112 A CA2148112 A CA 2148112A CA 2148112 A CA2148112 A CA 2148112A CA 2148112 A1 CA2148112 A1 CA 2148112A1
Authority
CA
Canada
Prior art keywords
pharmaeutical
new
dosage form
transdermal administration
weight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA2148112A
Other languages
French (fr)
Other versions
CA2148112C (en
Inventor
Philippe Laurent
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cephalon France SAS
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2148112A1 publication Critical patent/CA2148112A1/en
Application granted granted Critical
Publication of CA2148112C publication Critical patent/CA2148112C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7015—Drug-containing film-forming compositions, e.g. spray-on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Nutrition Science (AREA)
  • Dermatology (AREA)
  • Materials Engineering (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The invention relates to a composition intended to form a film on the skin for the transdermal adminis-tration of an active principle, which comprises:
a) a lipophilic active principle b) from 5 to 60 % by weight of a silicone-based adhesive polymer composition c) from 0 to 25 % by weight of an absorption promoter, and d) from 25 to 95 % by weight of a volatile solvent.
CA002148112A 1994-04-29 1995-04-27 New pharmaeutical dosage form for transdermal administration Expired - Fee Related CA2148112C (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9405272A FR2719220A1 (en) 1994-04-29 1994-04-29 New galenic form for transdermal administration.
FR9405272 1994-04-29

Publications (2)

Publication Number Publication Date
CA2148112A1 true CA2148112A1 (en) 1995-10-30
CA2148112C CA2148112C (en) 2001-01-30

Family

ID=9462709

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002148112A Expired - Fee Related CA2148112C (en) 1994-04-29 1995-04-27 New pharmaeutical dosage form for transdermal administration

Country Status (16)

Country Link
EP (1) EP0679392B1 (en)
JP (1) JP2740465B2 (en)
KR (1) KR100233770B1 (en)
AT (1) ATE210430T1 (en)
AU (1) AU680731B2 (en)
CA (1) CA2148112C (en)
DE (1) DE69524470T2 (en)
DK (1) DK0679392T3 (en)
ES (1) ES2169746T3 (en)
FR (1) FR2719220A1 (en)
HK (1) HK1008658A1 (en)
HU (1) HU221599B (en)
NZ (1) NZ272014A (en)
PT (1) PT679392E (en)
TW (1) TW448050B (en)
ZA (1) ZA953392B (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2740038B1 (en) * 1995-10-20 1998-01-02 Lafon Labor COMPOSITION FOR TRANSDERMAL ADMINISTRATION
DE69717847T2 (en) * 1996-10-24 2003-09-18 The Procter & Gamble Company, Cincinnati SKIN ODOR REDUCTION COMPOSITIONS
US5968919A (en) * 1997-10-16 1999-10-19 Macrochem Corporation Hormone replacement therapy drug formulations for topical application to the skin
DE19830732B4 (en) * 1998-07-09 2008-11-13 Lts Lohmann Therapie-Systeme Ag Composition containing at least one substance influencing blood lipid levels and its use
US6512072B1 (en) 2000-06-12 2003-01-28 Dow Corning Corporation Fast cure film forming formulation
FR2827764B1 (en) * 2001-07-27 2005-08-19 Oreal COMPOSITION, IN PARTICULAR COSMETIC, CONTAINING A STEROID AND A GLYCOL
ATE388697T1 (en) * 2003-11-21 2008-03-15 Galderma Res & Dev SPRAYABLE COMPOSITION FOR ADMINISTRATION OF VITAMIN D DERIVATIVES
FR2867682B1 (en) * 2004-03-22 2009-06-05 Galderma Res & Dev ANHYDROUS PHARMACEUTICAL COMPOSITION COMPRISING A SILICONE AGENT AND A SOLUBILIZED ACTIVE INGREDIENT.
KR20070027587A (en) * 2004-06-17 2007-03-09 갈데르마 소시에떼아노님 Composition for the treatment of psoriasis comprising a silicone agent, a corticosteroid and vitamin d or a derivative thereof
FR2871695B1 (en) 2004-06-17 2008-07-04 Galderma Sa PHARMACEUTICAL COMPOSITION COMPRISING A SILICONE AGENT AND TWO SOLUBILIZED ACTIVE INGREDIENTS
FR2887150B1 (en) * 2005-06-17 2007-08-03 Galderma Res & Dev PHARMACEUTICAL COMPOSITION COMPRISING AN ORGANOPOLYSILOXANE ELASTOMER AND A SOLUBILIZED ACTIVE INGREDIENT
FR2909284B1 (en) * 2006-11-30 2012-09-21 Galderma Sa NOVEL VASELIN-FREE OINTMENTAL COMPOSITIONS COMPRISING VITAMIN D DERIVATIVE AND POSSIBLY STEROID ANTI-INFLAMMATORY
US10265265B2 (en) 2007-03-15 2019-04-23 Drug Delivery Solutions Limited Topical composition
EP2008651A1 (en) 2007-06-26 2008-12-31 Drug Delivery Solutions Limited A bioerodible patch
JP6105494B2 (en) 2011-03-14 2017-03-29 ドラッグ デリバリー ソリューションズ リミテッド Ophthalmic composition
US20130323332A1 (en) * 2012-05-31 2013-12-05 Sherry May Raymond-Coblantz Hand and body moisturizing serum
EP3542788A1 (en) 2018-03-19 2019-09-25 MC2 Therapeutics Limited Topical composition comprising calcipotriol and betamethasone dipropionate

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3836647A (en) * 1970-10-22 1974-09-17 Dow Corning Wash-resistant skin preparation
DE2140491A1 (en) * 1971-08-12 1973-02-22 Pawlowa Bactericidal compsns - contg a quaternary base, a filmogenic polymer and a solvent
US4584192A (en) * 1984-06-04 1986-04-22 Minnesota Mining & Manufacturing Company Film-forming composition containing an antimicrobial agent and methods of use
EP0289900A1 (en) * 1987-04-30 1988-11-09 Abbott Laboratories Topical antibacterial compositions
JPH02145512A (en) * 1988-11-26 1990-06-05 Shin Etsu Chem Co Ltd External preparation of film forming type
IN172390B (en) * 1989-07-18 1993-07-10 Ethicon Inc
DE69007886T2 (en) * 1989-07-21 1994-11-17 Izhak Blank Oestradiol containing agents and methods for topical use.
TW247878B (en) * 1991-07-02 1995-05-21 Takeda Pharm Industry Co Ltd
GB9114346D0 (en) * 1991-07-03 1991-08-21 Dow Corning Sa A method of accelerating drug permeation
EP0560014A1 (en) * 1992-03-12 1993-09-15 Atrix Laboratories, Inc. Biodegradable film dressing and method for its formation

Also Published As

Publication number Publication date
AU1767595A (en) 1995-11-16
NZ272014A (en) 1997-05-26
AU680731B2 (en) 1997-08-07
FR2719220B1 (en) 1997-02-14
HUT75251A (en) 1997-05-28
ATE210430T1 (en) 2001-12-15
PT679392E (en) 2002-05-31
KR100233770B1 (en) 1999-12-01
HU9501245D0 (en) 1995-06-28
TW448050B (en) 2001-08-01
DE69524470T2 (en) 2002-05-23
EP0679392B1 (en) 2001-12-12
ZA953392B (en) 1996-10-28
FR2719220A1 (en) 1995-11-03
HK1008658A1 (en) 1999-05-14
JPH0859456A (en) 1996-03-05
ES2169746T3 (en) 2002-07-16
EP0679392A1 (en) 1995-11-02
CA2148112C (en) 2001-01-30
DK0679392T3 (en) 2002-04-08
KR950028767A (en) 1995-11-22
DE69524470D1 (en) 2002-01-24
JP2740465B2 (en) 1998-04-15
HU221599B (en) 2002-11-28

Similar Documents

Publication Publication Date Title
CA2148112A1 (en) New pharmaeutical dosage form for transdermal administration
CA2153572A1 (en) Transdermal therapeutic system with galanthamine as active ingredient
ITMI961152A0 (en) THERAPEUTIC COMPOSITION FOR THE TRANSDERMAL ADMINISTRATION OF AN ACTIVE INGREDIENT, ESTROGEN OR PROGESTIN OR MIXTURES THEREOF
CA2004598A1 (en) Medicinal aerosol formulations
HUP9802983A2 (en) Transdermal delivery system comprising silicone derivatives
ATA189395A (en) ORAL PHARMACEUTICAL PREPARATION
WO2002045699A3 (en) Transdermal therapeutic system comprising the active ingredient oxybutynin
MY109939A (en) Patches for percutaneous administration of skin- whitening materials
IT8921118A0 (en) COMPOSITION FOR AEROSOL INCLUDING NITROGLYCERIN AS THE ACTIVE INGREDIENT.
AU632182B2 (en) Transdermal therapeutic system comprising as active component buprenorphine
AU4877090A (en) Therapeutic system for the retarded and controlled transdermal or transmucous administration of active substances
NO895172L (en) PROCEDURE FOR THE PREPARATION OF A TRANSDERMAL THERAPEUTIC SYSTEM WITH PHYTOSTIGMIN AS A SUBSTANCE.
EP0900565A4 (en) Patch containing isosorbide dinitrate
EP0380989A3 (en) Plaster for transdermal administration
EP0378413A3 (en) Compositions for topical treatment of skin disorders
AU4684389A (en) Transdermal therapeutic system comprising norpseudoephedrine as active component
CA2370023A1 (en) Transdermal therapeutic system with a highly effective neuroleptic agent
ATE35620T1 (en) PHARMACEUTICAL PREPARATION WITH RETARDED EFFECT.
CA2235346A1 (en) Composition for transdermal delivery
FR2694292B1 (en) Benzimidazole-2-thione- derivatives, their preparation and their use as medicaments.
AU1042888A (en) Pain-killer
RU95118764A (en) DRUG FOR TREATMENT OF PURULENT WASES ON THE BACKGROUND OF DIABETES MELLITUS

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed